LMAT (LeMaitre Vascular, Inc.) Stock Financials & Earnings

LMATLeMaitre Vascular, Inc.

Mkt Cap$3B

Revenue (TTM)$250M

Net Income (TTM)$58M

EPS (TTM)$2.51

Free Cash Flow (TTM)$74M

Gross Margin71.5%

Op. Margin27.2%

Net Margin23.1%

FCF Margin29.8%

P/S Ratio (TTM)10.0x

P/E Ratio (TTM)43.3x

YoY Rev Growth+13.5%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$47M	$31M	$8M
Q2 23	$50M	$32M	$9M
Q3 23	$47M	$31M	$9M
Q4 23	$49M	$33M	$10M
Q1 24	$53M	$37M	$12M
Q2 24	$56M	$38M	$14M
Q3 24	$55M	$37M	$13M
Q4 24	$56M	$39M	$13M
Q1 25	$60M	$41M	$13M
Q2 25	$64M	$45M	$16M
Q3 25	$61M	$46M	$20M
Q4 25	$64M	$46M	$19M

Revenue Breakdown

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 23	$4M	$8M	$11M
Q2 23	$5M	$8M	$10M
Q3 23	$4M	$8M	$10M
Q4 23	$4M	$8M	$10M
Q1 24	$4M	$9M	$12M
Q2 24	$4M	$9M	$11M
Q3 24	$4M	$9M	$11M
Q4 24	$4M	$9M	$13M
Q1 25	$4M	$10M	$14M
Q2 25	$4M	$10M	$15M
Q3 25	$3M	$11M	$12M
Q4 25	$4M	$10M	$13M

Revenue Segments

Revenue by Geography

Quarter	Americas	Asia Pacific	Emea
Q1 23	$32M	$3M	$12M
Q2 23	$34M	$3M	$14M
Q2 24	$37M	$4M	$15M
Q3 24	$36M	$4M	$15M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$17M	$64M	$81M
Q2 23	$19M	$71M	$90M
Q3 23	$18M	$79M	$97M
Q4 23	$24M	$81M	$105M
Q1 24	$27M	$82M	$108M
Q2 24	$22M	$91M	$113M
Q3 24	$21M	$103M	$124M
Q4 24	$26M	$274M	$300M
Q1 25	$25M	$277M	$303M
Q2 25	$27M	$292M	$319M
Q3 25	$25M	$318M	$343M
Q4 25	$28M	$331M	$359M

Shares Outstanding

Revenue Per Employee

Revenue / Employee